Adjuvant therapy for breast cancer video

NCCN Guidelines on Molecular Assays for Patients With Breast Cancer

NCCN Patient Webinar: Metastatic Breast Cancer

NCCN Guideline Changes for BRCA Testing in TNBC

Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit

Ovarian Cancer: Updates to NCCN Guidelines

Breast Cancer: Adding Pertuzumab as a Neoadjuvant Treatment Option

Adjuvant treatment for high risk HR+ breast cancer | ESMO 2023 Breast Cancer Highlights

UCSF at #ASCO25: Scott Swartz on NCCN guidelines for cancer care in Sub-Saharan Africa (SSA)

31 First Line Therapy: The Role of Biomarkers and NCCN Guidelines

Neoadjuvant treatment approach for HER2 positive breast cancer

Prognostic trials for 21-gene OncotypeDX in HR+/HER2- breast cancer with micrometastases

NBE- NEOADJUVANT THERAPY AND DE-ESCALATION OF SURGICAL MANAGEMENT IN BREAST CANCER- DR. NITA NAIR

Emerging Options for BRCA-Mutated Breast Cancer Treatment

Immunotherapy for TNBC in the Perioperative Setting: Clinical Evidence and Considerations

Neoadjuvant Chemotherapy for Gastric Cancer Patients

Updates in Extended Endocrine Therapy for HR+ Breast Cancer | ASCO21 & National Practice Guidelines

HER-2+ Breast Cancer - Russell

Management of patients after adjuvant Truztuzumab and pertuzumab

Controversy Debate 4: Treatment algorithms in metastatic CRC - NCCN guidelines